More information can be found on UKADs website here.
If lab shows that it is deficient, it is billable to insurance by the practitioner
But the thing is, and I also published a paper on this back in 2019 or something like that, about DHA and phospholipid form getting into the brain through a different mechanism than DHA in triglyceride form
[2] This led to publications authored in part by Sinclair in both Nature and Science in 2003
These agents act on multiple physiological pathways involved in type 2 diabetes with the effect of increasing insulin secretion and decreasing glucagon to control glucose levels (1,2)
What it can support is the physical comfort side of weaning, reduced pumping, dropped feeds, and feeding transitions